Skip to content

Marathon Runners Compared to Sedentary Matched Control Subjects

Fitness, Glucosemetabolism, Cognitive Function, Bodycomposition and Muscular Function in Active Runners and Matched Controls

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02001805
Enrollment
200
Registered
2013-12-05
Start date
2010-12-31
Completion date
2013-12-31
Last updated
2013-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

The investigators wish to compare very active runners in healthy untrained control subjects on a number of parameters. The project aims to understand the underlying mechanisms by which physical inactivity causes diseases. This the investigators will study the full spectrum of physical activity, from the most inert of the most active people. The investigators have already collected muscle biopsies and established stem cells from people with Type 2 diabetes, obese healthy and normal weight healthy. In this study, the investigators will establish a cohort of highly physically active marathon runners. In a case-control design, the investigators compare muscle stem cell function across the entire spectrum of physical activity / inactivity.

Detailed description

There has never been as much focus on running as in these days. With the knowledge the investigators have today, there is reason to believe that it is healthy to run both in a physical sense, but perhaps also in terms of brain function. However, there has not previously carried out extensive comparative studies of very active runners and healthy untrained control subjects. In this project the investigators will characterize the degree of training in subjects as the investigators will carry out various forms of physiological studies on the subjects' fitness level. The investigators will examine whether there is a linkage between training level and brain function. The investigators will also examine muscle function at the molecular level. The investigators will isolate stem cells (satellite cells) from muscles biopsy and establish primary muscle cell cultures. By electrical stimulation of these cells in vitro, the investigators can emulate a muscle contraction as during physical activity. The investigators will test the overall hypothesis that physical activity affects stem cell function. The investigators will further study whether epigenetic phenomena (methylation) of selected DNA sequences are sensitive to training level.

Interventions

None listed

Sponsors

The Augustinus Foundation, Denmark.
CollaboratorOTHER
Inge Holm
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* 10 marathons, 2 within the last year or 50 km/week the last 5 years

Exclusion criteria

* smokers, any medication, chronic diseases, digestion of performance enhancing drugs, pregnancy, alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
Fitnessone dayLactate threshold VO2max Running economy Lactate Peak
Cognitive Functionone dayMemory, concentration, personality, intelligence
Bloodone day3 hour Oral Glucose Tolerance test (glucose, insulin, c-peptide) Fasting blood measurements ( lever, kidney, immune system, colesterol parameters) DNA
Muscle biopsyone dayGene transcription Methylation
Body Compositionone dayDXA scanning: Fat%, muscle mass, lean body mass, BMD MR scanning: Amount of visceral fat, volume of thighs

Secondary

MeasureTime frameDescription
Activity level and diet7 daysSubjects are carrying a step pedometer for 7 days They are registrering their diet for 4 days They are answering questionaires about daily activity level and health now and in the past

Countries

Denmark

Contacts

Primary ContactLouise S Hansen, Cand. Scient
louise_seier_84@hotmail.com35450746
Backup ContactMatthew Laye, Post doc
mjlaye@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026